Correlation Between North Dallas and Exagen
Can any of the company-specific risk be diversified away by investing in both North Dallas and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining North Dallas and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between North Dallas Bank and Exagen Inc, you can compare the effects of market volatilities on North Dallas and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in North Dallas with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of North Dallas and Exagen.
Diversification Opportunities for North Dallas and Exagen
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between North and Exagen is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding North Dallas Bank and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and North Dallas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on North Dallas Bank are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of North Dallas i.e., North Dallas and Exagen go up and down completely randomly.
Pair Corralation between North Dallas and Exagen
Given the investment horizon of 90 days North Dallas Bank is expected to under-perform the Exagen. But the pink sheet apears to be less risky and, when comparing its historical volatility, North Dallas Bank is 3.45 times less risky than Exagen. The pink sheet trades about -0.08 of its potential returns per unit of risk. The Exagen Inc is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 256.00 in Exagen Inc on October 5, 2024 and sell it today you would earn a total of 53.00 from holding Exagen Inc or generate 20.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 69.05% |
Values | Daily Returns |
North Dallas Bank vs. Exagen Inc
Performance |
Timeline |
North Dallas Bank |
Exagen Inc |
North Dallas and Exagen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with North Dallas and Exagen
The main advantage of trading using opposite North Dallas and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if North Dallas position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.North Dallas vs. CCSB Financial Corp | North Dallas vs. Delhi Bank Corp | North Dallas vs. Bank of Utica | North Dallas vs. First Community |
Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |